Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.33 |
| ▸ | PYGB | P11216 | 3/20 | 0.33 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.33 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.33 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.33 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24778537 | 0.87 | L3MBTL1 (0.40) | L3MBTL1MAPTPOLBLGALS3PYGB | |
| SCHEMBL19753214 | 0.84 | L3MBTL1 (0.45) | L3MBTL1MAPTPOLBLGALS3PYGB | |
| SCHEMBL21517580 | 0.82 | L3MBTL1 (0.36) | L3MBTL1MAPT | |
| SCHEMBL24251933 | 0.80 | IGF2R (0.48) | L3MBTL1MAPTLGALS3LGALS8GAA | |
| SCHEMBL21972113 | 0.75 | L3MBTL1 (0.41) | L3MBTL1MAPTPOLBLGALS3PYGB | |
| SCHEMBL18701069 | 0.74 | AMY1A (0.41) | L3MBTL1MAPTLGALS3LGALS8GAA | |
| SCHEMBL16592337 | 0.74 | AMY1A (0.41) | L3MBTL1MAPTLGALS3LGALS8GAA | |
| SCHEMBL24779615 | 0.74 | AMY1A (0.34) | AMY1A | |
| SCHEMBL22561612 | 0.74 | ALDH1A1 (0.32) | L3MBTL1MAPT | |
| SCHEMBL20753968 | 0.73 | L3MBTL1 (0.38) | L3MBTL1MAPTPOLBLGALS3PYGB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11092565-B2 | Electrochemical methods and compounds for the detection of enzymes | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2021-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11092565-B2 | Electrochemical methods and compounds for the detection of enzymes | EPX, DNASE1, DERA | L3MBTL1 2209/4885MAPT 4102/4885POLB 101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.